title: Prevention of graft infection by use of prostheses bonded with a rifampin/collagen release system.
abstract: The objective of this study was to test the efficacy of bonding rifampin to double-velour Dacron grafts with collagen to prevent graft sepsis. Fifty 6.0 mm Dacron grafts (length 5.0 cm) impregnated with either collagen (control) or collagen plus rifampin (experimental) were implanted in dogs end-to-end into the infrarenal aorta. The dogs were divided into four groups (each with an experimental and control subdivision) as a function of time between grafting and bacterial challenge. At 2, 7, 10, or 12 days after graft implantation, sequential groups were challenged with 1.2 x 10(8) colony forming units of Staphylococcus aureus (clinical isolate) intravenously suspended in 250 ml normal saline. Three weeks after hematogenous seeding, the grafts were sterilely harvested. One-tailed Fisher's exact test was used to compare the patency and culture-proven infection of control and antibiotic coated grafts as a function of implantation time before bacteremic challenge. In the 2-day group, four of six control grafts were infected compared with zero of six experimental grafts (p less than 0.030). In the 7-day group, five of six control grafts were infected with S. aureus versus zero of six in the experimental group (p less than 0.008). In the 10-day group, one of six experimental grafts was infected, but the control group had only two of six graft infections. In the 12-day group two of six experimental grafts and one of five control grafts were infected. These results indicate that rifampin bonded with collagen to knitted Dacron grafts will protect the graft from bacteremic infection for 7 days after implantation in a highly challenging model.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Surgery, UCLA Center for the Health Sciences 90024-6904.
authors.forename: A
authors.initials: A
authors.lastname: Chervu
authors.forename: W S
authors.initials: WS
authors.lastname: Moore
authors.forename: H A
authors.initials: HA
authors.lastname: Gelabert
authors.forename: M D
authors.initials: MD
authors.lastname: Colburn
authors.forename: M
authors.initials: M
authors.lastname: Chvapil
mesh_terms: D000714:Anastomosis, Surgical; D000818:Animals; D001012:Aorta, Abdominal / Q000601:surgery; D016470:Bacteremia / Q000517:prevention & control; D001807:Blood Vessel Prosthesis; D003094:Collagen / Q000737:chemistry*; D004285:Dogs; D011093:Polyethylene Terephthalates / Q000737:chemistry*; D011474:Prosthesis Design; D012293:Rifampin / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use*; D013203:Staphylococcal Infections / Q000517:prevention & control*; D013997:Time Factors; D014654:Vascular Patency
chemical_list: D011093:Polyethylene Terephthalates; D003094:Collagen; D012293:Rifampin